Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition
Author:
Funder
National Research Foundation of Korea
Ministry of Science, ICT and Future Planning
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference32 articles.
1. Tumour cell secretome in chemoresistance and tumour recurrence;Madden;Trends in cancer,2020
2. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations;Sharma;Cell,2010
3. Stem cell programs in cancer initiation, progression, and therapy resistance;Huang;Theranostics,2020
4. Balancing safety and efficacy of epidermal growth factor receptor inhibitors in patients with squamous cell carcinoma of the head and neck;Iberri;Oncol.,2015
5. Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer;Byeon;Exp. Mol. Med.,2019
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review;Biology;2024-02-06
2. KCNA1 promotes the growth and invasion of glioblastoma cells through ferroptosis inhibition via upregulating SLC7A11;Cancer Cell International;2024-01-03
3. The mitochondrial regulation in ferroptosis signaling pathway and its potential strategies for cancer;Biomedicine & Pharmacotherapy;2023-12
4. Iron, Ferroptosis, and Head and Neck Cancer;International Journal of Molecular Sciences;2023-10-12
5. Ferroptosis: a potential therapeutic target for stroke;Neural Regeneration Research;2023-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3